Evaluation of the utility of using pleural fluid cholesterol as a new criterion for the differential diagnosis between transudates and exudates

K. Kosmidis, S. Patiakas (Kastoria, Greece)

Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Session: The new clinical spectrum of lung diseases: from bronchi to pleura
Session type: Poster Discussion
Number: 498

Congress or journal article abstract

Abstract

OBJECTIVE: To study two alternative criteria to differentiate between exudates and transudates:a) pleural fluid cholesterol and b)the ratio of pleural fluid cholesterol to serum cholesterol in order to compare their diagnostic value with the widely accepted and used Light‘s criteria.
MATERIAL - METHOD: 97 patients with pleural effusion were tested. According to Light‘s criteria there were 29 transudative and 68 exudative pleural effusions. Pleural fluid and serum levels of lactate dehydrogenase, protein and cholesterol were measured using colorimetric methods and a biochemical analyzer.
RESULTS: Using as a cut-off value for the pleural fluid cholesterol the value of 65mg% (the upper limit to identify a pleural effusion as a transudate) this criterion yielded a sensitivity of 87% and a specificity of 79%. Using the alternative criterion of pleural fluid cholesterol to serum cholesterol ratio(and a cut-off level of 0,4 as the upper limit to identify a transudate) the sensitivity was 87% and the specificity was even greater at 81%.
CONCLUSIONS: This study showed that using pleural fluid cholesterol and pleural fluid cholesterol/serum cholesterol ratio may be useful for the differential diagnosis between transudates and exudates, and can provide assistance especially where other criteria are marginal or ambiguous.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Kosmidis, S. Patiakas (Kastoria, Greece). Evaluation of the utility of using pleural fluid cholesterol as a new criterion for the differential diagnosis between transudates and exudates. Eur Respir J 2011; 38: Suppl. 55, 498

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of pleural cholesterol in distinguishing transudates from exudates
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

Evaluation of efficacy of discrimination of pleural transudates and exudates by measuring specific gravity of pleural effusion fluid using refractometer
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006

Is pleural cholesterol useful for differentiation between exudates and transudates?
Source: Eur Respir J 2005; 26: Suppl. 49, 447s
Year: 2005

Comparison of the effectiveness of Light criteria and some other proposed criteria in differentiation of pleural fluids as exudates or transudates
Source: Annual Congress 2003 - Pleural effusion
Year: 2003


Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 455s
Year: 2006

Diagnostic yield of sl-selectin in differentiation of transudates from exudates in pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Incidence and diagnostic utility of pleural fluid eosinophilia
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008

Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009

Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Diagnostic utility of pleural fluid eosinophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 439s
Year: 2002

Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012


The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Reumathoid factor: diagnostic utility in pleural fluid
Source: Eur Respir J 2003; 22: Suppl. 45, 191s
Year: 2003

Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Diagnostic utility of biochemical parameters in patients with pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009